(Q41684128)

7 October 2017

title

Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis (English)

1 reference

7 October 2017

1 reference

Yacyshyn B

1

1 reference

7 October 2017

Maksymowych W

series ordinal

2

1 reference

7 October 2017

Bowen-Yacyshyn MB

series ordinal

3

1 reference

7 October 2017

publication date

1 August 1999

1 reference

7 October 2017

1 reference

7 October 2017

volume

60

1 reference

7 October 2017

issue

8

1 reference

7 October 2017

page(s)

677-687

1 reference

Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

The multidrug resistance (mdr1) gene product functions as an ATP channel

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Multidrug transporter p‐glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: Modulation with differentiation stage and during aging

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

ABC Transporters: From Microorganisms to Man

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Reduced cyclosporin accumulation in multidrug-resistant cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Inflammatory bowel disease: etiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900036-1

7 January 2021

10.1016/S0198-8859(99)00036-1

Identifiers

DOI

1 reference

7 October 2017

1 reference